NCT02918929View on ClinicalTrials.gov

A Study of EDP 305 in Healthy Subjects and Subjects With Presumptive NAFLD

PHASE1CompletedINTERVENTIONAL
Enrollment

146

Participants

Timeline

Start Date

September 30, 2016

Primary Completion Date

June 30, 2017

Study Completion Date

June 30, 2017

Conditions
Presumptive NAFLD
Interventions
DRUG

EDP 305

DRUG

Placebo

placebo to match EDP 305

Trial Locations (1)

66219

Pharmaceutical Research Associates, Inc.,, Lenexa

Sponsors
All Listed Sponsors
collaborator

Pharmaceutical Research Associates

OTHER

lead

Enanta Pharmaceuticals, Inc

INDUSTRY